|1.||Gilbert, Ian H: 2 articles (09/2005 - 02/2004)|
|2.||Harwood, John L: 2 articles (09/2005 - 02/2004)|
|3.||Urch, Jonathan E: 2 articles (09/2005 - 02/2004)|
|4.||Jones, Simon M: 2 articles (09/2005 - 02/2004)|
|5.||Berry, Colin: 2 articles (09/2005 - 02/2004)|
|6.||Brun, Reto: 2 articles (09/2005 - 02/2004)|
|7.||Besra, Gurdyal S: 2 articles (11/2003 - 10/2002)|
|8.||Bisht, Surendra S: 1 article (01/2006)|
|9.||Singh, Biswajit K: 1 article (01/2006)|
|10.||Tripathi, Rama P: 1 article (01/2006)|
01/01/2006 - "Thiolactomycin, a clinical candidate for treatment of tuberculosis has led to further explorations in this class. "
11/03/2003 - "tuberculosis mycolic acid biosynthesis, compared to thiolactomycin."
10/01/2002 - "tuberculosis strains with multicopy inhA or kasAB plasmids, were tested for their resistance to INH, ethionamide (ETH) or thiolactomycin (TLM). "
09/01/2003 - "tuberculosis to treatment with the mycolic acid biosynthesis inhibitors isoniazid, thiolactomycin, and triclosan. "
02/15/2004 - "A series of analogues of the naturally occurring antibiotic thiolactomycin (TLM) have been synthesised and evaluated for their ability to inhibit the growth of the malaria parasite, Plasmodium falciparum. "
09/22/2005 - "Analogues of the natural antibiotic thiolactomycin (TLM), an inhibitor of the condensing reactions of type II fatty acid synthase, were synthesized and evaluated for their ability to inhibit the growth of the malaria parasite Plasmodium falciparum. "
|5.||Periodontal Diseases (Periodontal Disease)
|1.||Mycolic Acids (Mycolic Acid)
|4.||Fatty Acid Synthetase Complex (Fatty Acid Synthase)